UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in SUPN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,575,073
+$553,887 QoQ
Shares Held
107,856
+6.8% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 43.63317757009346.ToString("F0")%
Shared 0.ToString("F0")%
None 56.366822429906534.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. SUPN ranks #11 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,398,351 | $519,929,066 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
207,309 | $122,930,085 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
571,719 | $75,318,257 | |
| 4 | VTRS |
Viatris Inc
|
3,964,630 | $53,562,146 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
486,498 | $36,900,870 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,526,922 | $36,539,240 | |
| 7 | ALKS |
Alkermes plc.
|
403,153 | $14,255,486 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
443,527 | $9,207,616 |
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,575,073 | 107,856 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,021,186 | 101,030 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,827,838 | 101,022 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,285,650 | 167,692 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,530,088 | 107,789 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,616,720 | 100,020 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,500,508 | 80,196 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,475,416 | 92,539 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,752,126 | 51,367 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,486,560 | 51,367 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,316,024 | 47,734 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,670,792 | 55,582 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,013,734 | 55,582 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,038,254 | 57,142 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,986,891 | 58,697 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,521,798 | 52,621 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,731,219 | 53,565 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,282,339 | 43,976 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,207,750 | 45,285 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,394,324 | 45,285 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,116,051 | 42,630 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,072,570 | 42,630 | Shares | Sole | 2021-03-01 | |
| 2020-09-30 | $888,407 | 42,630 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,012,461 | 42,630 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $557,455 | 30,987 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||